Cases and evidence
Current product policyLast updated September 30, 2026
Choose a topic, then explore how a case reaches a judgment.
Prioritize validating import costs, acceptable price points, channel costs and margin structure, and brand recall and channel preference — this evidence determines whether any business model or registration choice has a valid foundation. If margins and brand demand don't hold up, investment in registration and partnerships would be wasted.
Read the full case →Recommend launching a short, stoppable portfolio validation first, checking regional demand, gross margin, customer contracts, regulatory and service requirements item by item before classifying disposition, because current sales volume evidence alone cannot support irreversible full-scale elimination
Read the full case →Recommend first building a time-bound, reversible portfolio comparison that specifies success probabilities, capital requirements, time distributions, and worst-case branches for each path (internal R&D, increased marketing, acquisition) before deciding. This is because a common baseline is currently missing (F4) and downside information is incomplete (F3, U1, U2), making a rushed commitment an irreversible risk (F5).
Read the full case →Prioritize the path of 'setting a time-bound, stoppable evidence gate for application and adoption': given that F2 shows application, adoption, specifications, volume, and pricing are all unvalidated, and F4 indicates that immediate full-scale commitment would create irreversible cost, validating key assumptions at low cost first before deciding whether to escalate to a full development commitment is currently the only path that preserves both the time window and reversibility.
Read the full case →Establish a time-boxed, stoppable R&D performance and portfolio evidence gate first, requiring each product to submit minimum evidence on strategic role, roadmap, customer outcomes, and spend-to-progress linkage before comparing trade-offs; this path avoids harming effective investments without evidence, or allowing sunk costs to grow unchecked
Read the full case →Adopt a time-boxed, stoppable regional, segment, and access evidence gate to sequence the launch, since there is currently no jointly validated evidence supporting full commitment, and all three teams agree that any initial investment must be stoppable; this path preserves the competitive window while avoiding irreversible risk
Read the full case →Prioritize launching a time-boxed, stoppable evidence gate on journey friction and value causality before deciding whether to scale into a three-year commitment, since baselines, root causes, and cross-journey dependencies remain unknown (U1, U2, U3); locking in three-year funding immediately carries irreversible risk and may rest on flawed causal assumptions (C1).
Read the full case →Recommend closing evidence gaps before phased investment: until three key uncertainties—bottleneck location, data representativeness, and clinical adoption capacity—are resolved, avoid irreversible resource lock-in from simultaneously betting heavily on multiple solutions
Read the full case →Prioritize a time-boxed adjacent-market experiment with funding gates and stop-loss triggers. Given the current lack of evidence on customer payment, channels, and profitability, an immediate harvest-and-sell would forgo unvalidated upside in enterprise value, whereas the experiment path preserves exit flexibility at controlled cost.
Read the full case →Independent teaching simulation. The named consulting firm supplied the public source only; it did not use, review, endorse, sponsor, certify or commission Minerva Advisor. This evidence does not claim customer results, ROI or a permanent service-level guarantee.
All cases and validation →MINERVA DECISION READINESS REVIEW
Minerva separates evidence, inference and unknowns, then shows options, the strongest objection and what would reverse the recommendation.
Start a Minerva Decision Readiness ReviewBring a real, de-identified decision. Google sign-in and product access are required; your plan and Decision Credits apply. You remain the decision-maker, and no email or external action is sent automatically.